Nasdaq · Healthcare
Willdan Group, Inc. (WLDN)
As-reported financials and recent SEC filings for Willdan Group, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$681.6M
Net income
$52.6M
Net margin
7.7%
Diluted EPS
$3.49
ROE
17.2%
P/E (TTM)
21.9×
Market cap
$1.23B
Debt / equity
0.2×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $681.6M | $565.8M | $510.1M | $429.1M | $353.8M |
| Gross profit | $255.7M | $202.8M | $179.8M | $143.6M | $135.9M |
| Operating income | $44.1M | $31.4M | $22.1M | $-7.1M | $-8.7M |
| Net income | $52.6M | $22.6M | $10.9M | $-8.4M | $-8.4M |
| Diluted EPS | $3.49 | $1.58 | $0.80 | $-0.65 | $-0.68 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
S-82026-06-26
View on EDGAR →42026-06-18
View on EDGAR →42026-06-18
View on EDGAR →42026-06-18
View on EDGAR →42026-06-18
View on EDGAR →42026-06-18
View on EDGAR →42026-06-18
View on EDGAR →8-K2026-06-18
View on EDGAR →Go deeper on WLDN
Search Willdan Group, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.